Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Solomon

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Circulation|October 2, 2022
Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF StudyJames L Januzzi, Alaa Mabrouk Salem Omar, Yuxi Liu, et al.
Journal of Atrial Fibrillation|May 13, 2017
Preoperative Statin use is not Associated with a Reduced Risk of Atrial Fibrillation After Cardiac SurgeryBrian J Barnes, Scott Solomon, Patricia A Howard, et al.
European Heart Journal|November 2, 2013
Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRTNitesh Sood, Anne-Christine H Ruwald, Scott Solomon, et al.
The American Journal of Cardiology|August 14, 2014
Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)Saadia Sherazi, Ilan Goldenberg, Arthur J Moss, et al.
Journal of the American College of Cardiology|February 12, 2011
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trialAysha Arshad, Arthur J Moss, Elyse Foster, et al.
European Heart Journal|May 9, 2026
Guideline-recommended medical therapy efficacy according to use of digoxin: RALES, EMPHASIS-HF, PARADIGM-HF, and DAPA-HF trialsRagnhild Helseth, Ryohei Ono, Brian Claggett, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2014
Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapyMindy Leech, Lawrence Morris, Moishe Stewart, et al.
Journal of Cardiac Failure|March 25, 2018
Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT TrialAkshay S Desai, Jiankang Liu, Marc A Pfeffer, et al.
European Journal of Heart Failure|February 7, 2015
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Carolyn S P Lam, Margaret McEntegart, Brian Claggett, et al.
Journal of the American College of Cardiology|February 21, 2006
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)John McMurray, Scott Solomon, Karen Pieper, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Circulation|October 2, 2022
Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF StudyJames L Januzzi, Alaa Mabrouk Salem Omar, Yuxi Liu, et al.
Journal of Atrial Fibrillation|May 13, 2017
Preoperative Statin use is not Associated with a Reduced Risk of Atrial Fibrillation After Cardiac SurgeryBrian J Barnes, Scott Solomon, Patricia A Howard, et al.
European Heart Journal|November 2, 2013
Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRTNitesh Sood, Anne-Christine H Ruwald, Scott Solomon, et al.
The American Journal of Cardiology|August 14, 2014
Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)Saadia Sherazi, Ilan Goldenberg, Arthur J Moss, et al.
Journal of the American College of Cardiology|February 12, 2011
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trialAysha Arshad, Arthur J Moss, Elyse Foster, et al.
European Heart Journal|May 9, 2026
Guideline-recommended medical therapy efficacy according to use of digoxin: RALES, EMPHASIS-HF, PARADIGM-HF, and DAPA-HF trialsRagnhild Helseth, Ryohei Ono, Brian Claggett, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2014
Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapyMindy Leech, Lawrence Morris, Moishe Stewart, et al.
Journal of Cardiac Failure|March 25, 2018
Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT TrialAkshay S Desai, Jiankang Liu, Marc A Pfeffer, et al.
European Journal of Heart Failure|February 7, 2015
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)Carolyn S P Lam, Margaret McEntegart, Brian Claggett, et al.
Journal of the American College of Cardiology|February 21, 2006
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)John McMurray, Scott Solomon, Karen Pieper, et al.
Pageof 12